Literature DB >> 26796811

[Analysis of the efficacy of gastric cancer screening in rural population in Henan Province].

Meng Zhang1, Xin Li2, Shaokai Zhang1, Qiong Chen1, Shuzheng Liu1, Lanwei Guo1, Jianbang Lu1, Xibin Sun1.   

Abstract

OBJECTIVE: To analyze the efficacy of endoscopic screening for gastric cancer in rural population in high risk areas of upper gastrointestinal cancer in Henan province.
METHODS: Subjects aged 40-69 years in the high risk areas were selected to participate in the endoscopic screening based on the cluster sampling, and screening-positive subjects were sampled for pathological examination. The data of screening were summarized and the detection rates of severe chronic atrophic gastritis, severe intestinal metaplasia, low grade intraepithelial neoplasia, high grade intraepithelial neoplasia, early and middle-late cancer were calculated, and the constituent ratio of early cancer cases was calculated. The detection rates and early diagnosis rates for the first round screening and follow-up screening were compared.
RESULTS: In the 5 years, a total of 88 263 subjects were endoscopically examined in the first round screening and 4 004 subjects were diagnosed with low grade intraepithelial neoplasia or above (the detection rate was 4.54%), in which 3 256 cases were with low grade intraepithelial neoplasia (the detection rate of 3.69%), 366 cases with high grade intraepithelial neoplasia (the rate of 0.41%), 199 cases with early cancer (the rate of 0.22%) and 183 cases with middle-late cancer (the rate of 0.21%). The number of cases of high grade intraepithelial neoplasia and early cancer was 565 and the early diagnosis rate was 75.53%. 1 894 subjects with severe chronic atrophic gastritis, severe intestinal metaplasia and low grade intraepithelial were followed up with a compliance of 66.32%. A total of 45 cases of early cancer were diagnosed, with a detection rate of 2.38% and early diagnosis rate of 100%. The detection rate and early diagnosis rate in the follow-up screening were both statistically significantly higher than that in the first round screening (P<0.01 for both).
CONCLUSION: The efficacy of endoscopic screening for gastric cancer is significant in high risk areas of upper gastrointestinal cancer, and improving the quality of follow-up screening will achieve a better performance of the screening.

Entities:  

Mesh:

Year:  2016        PMID: 26796811     DOI: 10.3760/cma.j.issn.0253-3766.2016.01.014

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  4 in total

1.  Incidence and mortality of gastric cancer in 2018 and their trends from 2010 to 2018 in Henan Province, China: results from a provincial population-based cancer registry.

Authors:  Qiong Chen; Chen Cheng; Yin Liu; Lanwei Guo; Huifang Xu; Hong Wang; Xiaoyang Wang; Luyao Zhang; Shaokai Zhang; Binbin Han
Journal:  Ann Transl Med       Date:  2022-09

2.  The relative survival and cure fraction of gastric cancer estimated through flexible parametric models using data from population-based cancer registration during 2003-2012 in Linzhou, China.

Authors:  Qiong Chen; Shu-Zheng Liu; Shao-Kai Zhang; Xiao-Qin Cao; Bian-Yun Li; Pei-Liang Quan; Lan-Wei Guo; Lee Dong; Xi-Bin Sun; Yawei Zhang; Jian-Gong Zhang
Journal:  Cancer Med       Date:  2020-01-28       Impact factor: 4.452

3.  Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study.

Authors:  Qiong Chen; Liang Yu; Chang-Qing Hao; Jin-Wu Wang; Shu-Zheng Liu; Meng Zhang; Shao-Kai Zhang; Lan-Wei Guo; Pei-Liang Quan; Nan Zhao; Ya-Wei Zhang; Xi-Bin Sun
Journal:  Cancer Med       Date:  2016-07-01       Impact factor: 4.452

4.  Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area.

Authors:  Hai-Fan Xiao; Shi-Peng Yan; Ji-Gang Li; Zhao-Hui Shi; Yan-Hua Zou; Ke-Kui Xu; Xian-Zhen Liao
Journal:  Cancer Med       Date:  2020-09-16       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.